What does Ironwood Pharmaceuticals, Inc. do?
Ironwood Pharmaceuticals, Inc., a biotechnology company, focuses on the development and commercialization of therapies for gastrointestinal (GI) and rare diseases in the United States and internationally. It sells linaclotide, a guanylate cyclase type-C (GC-C) agonist for the treatment of adults suffering from…
What is Ironwood Pharmaceuticals, Inc.'s P/E and P/B ratio?
Ironwood Pharmaceuticals, Inc. has a P/E ratio of 4.6 and a P/B ratio of -3.64.
What is Ironwood Pharmaceuticals, Inc.'s debt-to-equity ratio?
Ironwood Pharmaceuticals, Inc. has a debt-to-equity ratio of -2.28.
How much does Ironwood Pharmaceuticals, Inc. owe compared with what it owns?
Ironwood Pharmaceuticals, Inc. owes $1.57 for every $1 it owns (balance sheet Jun 2026), which means it owes more than it owns.
What is Ironwood Pharmaceuticals, Inc.'s Positivity rank?
Ironwood Pharmaceuticals, Inc. is ranked #6,485 of 6,774 companies globally and #3,737 of 4,000 in United States on PositoAI, with a Positivity Score of -21,069.
Does Ironwood Pharmaceuticals, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Ironwood Pharmaceuticals, Inc..
Where can I read the latest news about Ironwood Pharmaceuticals, Inc.?
Recent headlines about Ironwood Pharmaceuticals, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Ironwood Pharmaceuticals, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Ironwood Pharmaceuticals, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.